NCT03262662: A trial that was reported late by State University of New York at Buffalo
This trial has reported, although it was 230 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03262662 |
|---|---|
| Title | EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 1, 2017 |
| Completion date | April 5, 2021 |
| Required reporting date | April 5, 2022, midnight |
| Actual reporting date | Nov. 21, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 230 |